EVOFEM BIOSCIENCES, INC.
Returns on Capital
| Period | ROE | ROI | ROA |
|---|---|---|---|
| Mar 2015 | -11.8% | -10.2% | -9.6% |
| Jun 2015 | -19.1% | -16.3% | -14.8% |
| Sep 2015 | -52.7% | -42.5% | -32.8% |
| Mar 2016 | -71.6% | -61.1% | -51.9% |
| Jun 2016 | -42.8% | -36.4% | -30.4% |
| Sep 2016 | -243.0% | -243.0% | -220.1% |
| Dec 2016 | 7.9% | 7.9% | -99.0% |
| Mar 2017 | -58.3% | -58.3% | -49.1% |
| Jun 2017 | -100.0% | -100.0% | -79.3% |
| Sep 2017 | -1,526.5% | -1,526.5% | -1,185.2% |
| Dec 2017 | 6.7% | 6.7% | -493.2% |
| Mar 2018 | 377.5% | 377.5% | -768.0% |
| Jun 2018 | -442.1% | -442.1% | -88.8% |
| Sep 2018 | 183.1% | 183.1% | -122.7% |
| Dec 2018 | 64.1% | 64.1% | -373.6% |
| Mar 2019 | 62.6% | 62.6% | -558.7% |
| Jun 2019 | -99.0% | -99.0% | -65.1% |
| Sep 2019 | -57.3% | -57.3% | -35.4% |
| Dec 2019 | -81.3% | -81.3% | -44.9% |
| Mar 2020 | -1,875.2% | -1,875.2% | -122.4% |
| Jun 2020 | -76.8% | -76.8% | -39.0% |
| Sep 2020 | -74.4% | -74.4% | -26.6% |
| Mar 2021 | 338.4% | 338.4% | -49.4% |
| Jun 2021 | -372.9% | -372.9% | -30.7% |
| Sep 2021 | 125.9% | 125.9% | -109.8% |
| Mar 2022 | 24.9% | 24.9% | -92.2% |
| Jun 2022 | 58.3% | 58.3% | -235.6% |
| Sep 2022 | -114.7% | -114.7% | 211.7% |
| Mar 2023 | 4.2% | 4.2% | -9.0% |
| Jun 2023 | 15.4% | 15.4% | -60.8% |
| Sep 2023 | -117.1% | -117.1% | 495.5% |
| Mar 2024 | 6.8% | 6.8% | -58.5% |
| Jun 2024 | -1.9% | -1.9% | 15.8% |
| Sep 2024 | 3.3% | 3.3% | -9.9% |
| Mar 2025 | -1.4% | -1.4% | 7.4% |
| Jun 2025 | 2.6% | 2.6% | -12.4% |
| Sep 2025 | 2.1% | 2.1% | -11.4% |
| Mar 2026 | 7.0% | 7.0% | -73.4% |
| Jun 2026 | 12.6% | 12.6% | -146.7% |